Clinical features of patients with hepatocellular carcinoma treated with radiofrequency ablation therapy: developing a simple score to determine the need for immune-adjuvant therapy.
Fujimasa TadaAtsushi HiraokaKosuke NakataniKana MatsuokaMai FukumotoTakuya MatsudaEmi YanagiharaHironobu SanetoTaisei MurakamiKei OnishiHirofumi IzumotoShogo KitahataKozue Kanemitsu-OkadaTomoe KawamuraTaira KurodaJun HanaokaJota WatanabeHiromi OhtaniOsamu YoshidaMasashi HirookaHideki MiyataEiji TsubouchiMasanori AbeBunzo MatsuuraTomoyuki NinomiyaYoichi HiasaPublished in: Clinical journal of gastroenterology (2024)
HCC patients treated by RFA and with a high AD-ON score (≧2) should be considered for aggressive adjuvant-chemotherapy to prolong the period of recurrence beyond the MC.